cetpinhibition.org

HDL biology

In the Framingham Heart Study, low CETP or high PLTP activity predicts more than double the cardiovascular risk in men but not women (Atherosclerosis 2013)

Original title: Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study

Atherosclerosis · · 7

Robins SJ, Lyass A, Brocia RW, Massaro JM, Vasan RS

In 2679 Framingham Heart Study Offspring participants without cardiovascular disease (mean age 59 years, 56% women) followed for a mean of 10.4 years, during which 187 experienced a first cardiovascular disease (CVD) event, plasma cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP) activities were both associated with significantly increased CVD risk in men, but not women. Compared with a referent group with CETP at or above median and PLTP below median, men had significantly greater multivariable-adjusted hazard ratios for new CVD with high CETP and high PLTP (HR 2.27; 95% CI 1.23-4.20), low CETP and low PLTP (HR 2.23; 95% CI 1.19-4.17), or low CETP and high PLTP (HR 2.85; 95% CI 1.53-5.31), while in women all combinations showed non-significant hazard ratios near 1.0.

Read the paper (DOI)PubMed

Original abstract

Objective: Cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP) are two genetically-related plasma proteins involved in the exchange of cholesteryl esters and phospholipids between high-density lipoproteins (HDL) and other lipoproteins. Although low CETP and high PLTP activity both result in higher concentrations of plasma HDL-cholesterol (HDL-C), there is no evidence that either of these changes is associated with a decrease in cardiovascular disease (CVD) in a general population.

Methods: Plasma CETP and PLTP activities, measured by homogenous fluorometric assays using synthetic donor particle substrates, were related to the incidence of a first CVD event in Framingham Heart Study Offspring participants without CVD (n = 2679, mean age 59 y, 56% women) attending the 6th examination cycle (1995-98). Because of an effect modification by sex for both CETP and PLTP, analyzes were stratified by sex.

Results: During follow-up (mean 10.4 years) 187 participants experienced a first CVD event. In sex-specific Cox models, both CETP and PLTP as continuous and as binary variables were associated with significantly increased CVD in men, but not women. In men compared to a referent group with CETP ≥ median and PLTP < median, the multivariable-adjusted hazard ratio (HR) for new CVD events was significantly greater with either the combination of high CETP and high PLTP (HR 2.27, 95% CI 1.23-4.20); low CETP and low PLTP (HR 2.23, 95% CI 1.19-4.17); or low CETP and high PLTP (HR 2.85, 95% CI 1.53-5.31). In contrast, in women the multivariable-adjusted HR for new CVD events was non-significant and virtually equal to "1.0" with all combinations of high and low CETP or PLTP values.

Conclusions: Lower plasma CETP or higher PLTP activity was each associated with a significantly increased risk of CVD. Inexplicably, the increase in CVD associated with both lipid transfer proteins was confined to men.

epidemiologyHDL biology

Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.